Genesis Therapeutics Company
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.
Investors
Funding Status:
Early Stage Venture
Headquarters:
South San Francisco, California, United States
Founded Date:
2019-11-01
Employee Number:
11-50
Last Funding Type:
Series A
Total Funding:
56100000.0
Estimated Revenue:
$1M to $10M
Industry:
Medical BioTech
Investors Number:
13.0
Technology:
['BioTech & HealthTech']
Investor Type:
info@genesistherapeutics.ai
Last Funding Date:
2020-12-02